NeuroOne Medical Technologies Corp’s filing revealed that its Business Development Director Christianson Mark unloaded Company’s shares for reported $22203.0 on Sep 05 ’25. In the deal valued at $0.74 per share,30,000 shares were sold. As a result of this transaction, Christianson Mark now holds 231,238 shares worth roughly $0.22 million.
Then, Christianson Mark bought 30,000 shares, generating $24,210 in total proceeds.
Before that, Christianson Mark sold 10,000 shares. NeuroOne Medical Technologies Corp shares valued at $5,804 were divested by the Business Development Director at a price of $0.58 per share. As a result of the transaction, Christianson Mark now holds 261,491 shares, worth roughly $0.24 million.
Ladenburg Thalmann initiated its NeuroOne Medical Technologies Corp [NMTC] rating to a Buy in a research note published on May 05, 2025; the price target was $1.45. A number of analysts have revised their coverage, including Craig Hallum’s analysts, who decreased its forecast for the stock in late March from “a Buy” to “a Hold”.
Price Performance Review of NMTC
On Friday, NeuroOne Medical Technologies Corp [NASDAQ:NMTC] saw its stock jump 3.34% to $0.93. Over the last five days, the stock has gained 4.60%. Nevertheless, the stocks have risen 12.60% over the past one year.
How much short interest is there in NeuroOne Medical Technologies Corp?
A steep rise in short interest was recorded in NeuroOne Medical Technologies Corp stocks on 2025-08-29, growing by 35463.0 shares to a total of 0.19 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 0.15 million shares. There was a rise of 19.11%, which implies that there is a positive sentiment for the stock.
